Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report
Authors: Torbjörn Ogéus
Introduction: Knee pain is one of the most frequent musculoskeletal symptoms in young physically active males. In some cases, it is very painful, can be hard to treat, and often lead to heterotopic ossification of the patellar tendon. To our knowledge, there are no reported cases of remission of ossification after clinical intervention. Case presentation: A 13-year-old Swedish boy with a 3-year anamnesis of severe Osgood-Schlatter with significant ossification of the patellar tendon at the point of tuberositas tibiae, was treated with injections of Liquid Platelet-Rich Fibrin (C-PRF) and Heat-Coagulated Albumin Gel (ALB-PRF) using a horizontal centrifuge system. He recovered and presented a near complete remission of ossification of the patellar tendon two months after treatment and could return to sport after a 3-year break. Conclusion: This case raises the hypothesis that Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel may be an effective intervention in the treatment of Osgood-Schlatter disease. Further research is required to test this theory
Keywords: Osgood-Schlatter, PRF, ALB-PRF, PRP
Authors
Correspondence to:
Torbjörn Ogéus##, Karlavägen 1, Stockholms led- & smärtklinik tobbe@sls.nu
Publication history:
Received 26 Nov 2023
Revised 03 Feb 2024
Accepted 10 Feb 2024
Published online 02 Apr 2024
TO, . Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. EJMCR. Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366
TO, . Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. https://www.ejmcr.com/?mno=178850 [Access: May 09, 2024]. doi:
10.24911/ejmcr.173-1701008366
TO, . Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. EJMCR. Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366
TO, . Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. EJMCR, [cited May 09, 2024]; Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366
, T. O. & (0) Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. EJMCR, Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366
, Torbjorn Ogéus, and . 0. Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. European Journal of Medical Case Reports, Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366
, Torbjorn Ogéus, and . "Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report." European Journal of Medical Case Reports Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366
, Torbjorn Ogéus, and . "Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report." European Journal of Medical Case Reports Online First: 02 Apr, 2024. Web. 09 May 2024 doi:
10.24911/ejmcr.173-1701008366
, T. O. & (0) Treatment of Osgood-Schlatter disease in an adolescent athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel (ALB-PRF): a case report. European Journal of Medical Case Reports, Online First: 02 Apr, 2024. doi:
10.24911/ejmcr.173-1701008366